tm
Seeing Is Believing
tm
Seeing Is Believing
Poseida Therapeutics's activity chart (see below) currently has 22 price targets and 36 ratings on display.
Analysts average stock forecasts to be materialized ratio is 3.17% with an average time for these price targets to be met of 206.22 days.
Most recent stock forecast was given by JUSTIN ZELIN from BTIG on 26-Nov-2024. First documented stock forecast 17-Aug-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-May-2021
$12
1 years 10 months 2 days ago
(26-Nov-2024)
0/2 (0%)
$9.14 (319.58%)
Buy Since 04-Jan-2023
$9
$-0.5 (-5.26%)
1 years 10 months 2 days ago
(26-Nov-2024)
0/5 (0%)
$-0.38 (-4.05%)
Buy Since 18-May-2021
$10
$0.5 (5.26%)
$10
1 years 11 months 29 days ago
(30-Sep-2024)
1/7 (14.29%)
$7.14 (249.65%)
928
Buy Since 07-Jan-2022
$14
2 years 11 months 18 days ago
(10-Oct-2023)
0/4 (0%)
$11.27 (412.82%)
Buy Since 07-Jan-2022
$24
$14.5 (152.63%)
$24
4 years 7 months 10 days ago
(18-Feb-2022)
0/2 (0%)
$20.07 (510.69%)
What is PSTX (Poseida Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on PSTX (Poseida Therapeutics)?
Which analyst has the current lower performing score on PSTX (Poseida Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PSTX (Poseida Therapeutics)?
Which analyst is the currently most bullish on PSTX (Poseida Therapeutics)?
Which analyst is the currently most reserved on PSTX (Poseida Therapeutics)?
